Capricor Therapeutics Inc <CAPR.O>: B. Riley cuts to Neutral from Buy; cuts target price to $10 from $63
CAPR•Related News
Perma-Fix Q2 FY26 net loss widens to $(6) million; revenue totals $13 million
PESI•
CF Bankshares Q2 FY26 net income rises 18% to $5.9 million; net interest margin widens 24 basis points to 2.93%
CFBK•
BiomX amends USD 1.25 million Water.IO note, issues 800,000 restricted shares to settle accrued interest
PHGE•
FEMSA Q2 net income rises 64.9% to MXN 9.22 billion; revenue climbs 9.3% to MXN 231 billion vs FY25 quarter
FMX•
EVI Industries launches USD 10 million share buyback program
EVI•